Found: 50
Select item for more details and to access through your institution.
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00871-1
- By:
- Publication type:
- Article
Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 8, p. 1618, doi. 10.3390/ijms18081618
- By:
- Publication type:
- Article
Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 378, doi. 10.1111/bjh.17689
- By:
- Publication type:
- Article
Sudden blastic transformation in treatment‐free remission chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 543, doi. 10.1111/bjh.16245
- By:
- Publication type:
- Article
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 272, doi. 10.1002/ajh.26771
- By:
- Publication type:
- Article
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) and myelodysplastic syndrome with ring sideroblasts (MDS‐RS).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E246, doi. 10.1002/ajh.26182
- By:
- Publication type:
- Article
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 282, doi. 10.1002/ajh.26061
- By:
- Publication type:
- Article
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 241, doi. 10.1002/ajh.26047
- By:
- Publication type:
- Article
Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. E50, doi. 10.1002/ajh.26044
- By:
- Publication type:
- Article
An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
- Published in:
- Annals of Hematology, 2018, v. 97, n. 6, p. 945, doi. 10.1007/s00277-018-3297-6
- By:
- Publication type:
- Article
HyperCVAD versus pegaspargase‐containing regimens for Hispanic adults with newly diagnosed B‐cell acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 3, p. 392, doi. 10.1111/ejh.14125
- By:
- Publication type:
- Article
Treatment-Free Remission in Chronic Myeloid Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 12, p. 686
- By:
- Publication type:
- Article
Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.582213
- By:
- Publication type:
- Article
Decreasing delirium through music listening (DDM) in critically ill, mechanically ventilated older adults in the intensive care unit: a two-arm, parallel-group, randomized clinical trial.
- Published in:
- Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-022-06448-w
- By:
- Publication type:
- Article
Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure.
- Published in:
- Clinical Case Reports, 2018, v. 6, n. 1, p. 155, doi. 10.1002/ccr3.1264
- By:
- Publication type:
- Article
Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community Setting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. e222, doi. 10.1016/j.clml.2023.02.002
- By:
- Publication type:
- Article
MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S343, doi. 10.1016/S2152-2650(21)01798-5
- By:
- Publication type:
- Article
AML-162: Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S285, doi. 10.1016/S2152-2650(21)01684-0
- By:
- Publication type:
- Article
Poster: MDS-158: Updated Safety and Efficacy of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Treatment-Naïve, Higher-Risk Myelodysplastic Syndromes: Phase 1b Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01429-4
- By:
- Publication type:
- Article
Poster: AML-162: Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S212, doi. 10.1016/S2152-2650(21)01329-X
- By:
- Publication type:
- Article
LILRB4 Expression in CMML and MDS Based on Response to Hypomethylating Agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S341, doi. 10.1016/j.clml.2019.07.343
- By:
- Publication type:
- Article
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
MEK Inhibitor Binimetinib (MEK162) in Relapse and Refractory Acute Myeloid Leukemia: Results of a Phase I/II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S199, doi. 10.1016/j.clml.2018.07.046
- By:
- Publication type:
- Article
Therapy of Early Chronic Phase Chronic Myeloid Leukemia (CML-CP) with Lower Dose Dasatinib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S15, doi. 10.1016/j.clml.2017.09.043
- By:
- Publication type:
- Article
Randomized Phase II Study of Guadecitabine (SGI-110) Based Regimens Comparing Guadecitabine 5 days (SGI5), 10 days (SGI10), 5 days + Idarubicin (SGI5 + Ida), and 5 days + Cladribine (SGI5 + Clad), in Previously Untreated Patients ≥ 70 Years with Acute Myeloid Leukemia (AML)--a Bayesian Design.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S6, doi. 10.1016/j.clml.2017.09.032
- By:
- Publication type:
- Article
JAK2 V617F Acute Lymphoblastic Leukemia Secondary to Myeloproliferative Neoplasms (MPNs) or After Lenalidomide Exposure: Case Report and Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S254, doi. 10.1016/j.clml.2017.07.016
- By:
- Publication type:
- Article
Results of Second Salvage Therapy for Acute Myeloid Leukemia in the Modern Era.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S272, doi. 10.1016/j.clml.2017.07.047
- By:
- Publication type:
- Article
Therapy with Lower Dose Dasatinib in Newly Diagnosed Early Chronic Phase-Chronic Myeloid Leukemia (CML-CP).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S317, doi. 10.1016/j.clml.2017.07.119
- By:
- Publication type:
- Article
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 10, p. 1755, doi. 10.1093/cid/ciaa358
- By:
- Publication type:
- Article
Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00369
- By:
- Publication type:
- Article
Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 612, doi. 10.1002/ajh.25769
- By:
- Publication type:
- Article
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 984, doi. 10.1002/ajh.25553
- By:
- Publication type:
- Article
Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E188, doi. 10.1002/ajh.25490
- By:
- Publication type:
- Article
A phase II study of omacetaxine mepesuccinate for patients with higher‐risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 74, doi. 10.1002/ajh.25318
- By:
- Publication type:
- Article
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. 1221, doi. 10.1002/ajh.24500
- By:
- Publication type:
- Article
Impact of comorbidities by ACE-27 in the revised-IPSS for patients with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 509, doi. 10.1002/ajh.23675
- By:
- Publication type:
- Article
Prediction model for mortality after intracranial hemorrhage in patients with leukemia.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 7, p. 546, doi. 10.1002/ajh.22031
- By:
- Publication type:
- Article
Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?
- Published in:
- 2018
- By:
- Publication type:
- Letter
Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comorbidities predict worse prognosis in patients with primary myelofibrosis.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 19, p. 2996, doi. 10.1002/cncr.28857
- By:
- Publication type:
- Article
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 6, p. 567, doi. 10.1159/000506346
- By:
- Publication type:
- Article
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 17, p. 3113, doi. 10.1002/cncr.33622
- By:
- Publication type:
- Article
Phase 2 study of lenalidomide maintenance for patients with high‐risk acute myeloid leukemia in remission.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 11, p. 1894, doi. 10.1002/cncr.33409
- By:
- Publication type:
- Article
Job Characteristics and Employees' Organizational Citizenship Behavior in Healthcare Sector of Pakistan.
- Published in:
- Open Access Public Health & Health Administration Review, 2022, v. 1, n. 1, p. 1
- By:
- Publication type:
- Article